Washington State Albertsons Pharmacy Lawsuit, $900 Million Opioid Judgment, Safeway Findings and What Happens Next

On November 5, 2026, King County Superior Court Judge Janet M. Helson ruled that Albertsons Companies, Inc. and Safeway, Inc. substantially contributed to Washington’s opioid crisis by failing to prevent the misuse and diversion of prescription opioids through their pharmacy and distribution operations. The decision followed a nine-week non-jury trial.

The court ordered $800 million for opioid-crisis abatement and $100 million in civil penalties, a combined $900 million while the abatement award stands. It also awarded the state attorney fees and costs and entered a permanent injunction requiring stronger pharmacy safeguards. Washington Attorney General Nick Brown described it as the largest judgment ever awarded in Washington state history.

Albertsons denies wrongdoing and says it is considering an appeal.

Two points readers should know:

• This is a government enforcement lawsuit, not a consumer class action. The money is for abatement and civil penalties, not payments to people who filled prescriptions at Albertsons or Safeway pharmacies.
• The ruling is a trial-court decision and can be appealed.

Quick Facts: State of Washington v. Albertsons Companies and Safeway

Detail	Information
Case name	State of Washington v. Rite Aid Corp. et al.
Case number	22-2-20910-1 SEA
Court	King County Superior Court, Washington
Judge	Janet M. Helson
Plaintiff	State of Washington (Attorney General’s Office)
Defendants at trial	Albertsons Companies, Inc. and Safeway, Inc.
Complaint filed	December 21, 2022 (then-Attorney General Bob Ferguson)
Trial	July 13, 2026 to September 14, 2026 (non-jury)
Written decision	November 5, 2026 (219 pages)
Abatement award	$800 million
Civil penalties	$100 million while the abatement award stands
Alternative CPA penalty	$337,921,650 if the abatement is reduced or eliminated
Fees and costs	Awarded; amount to be set
Legal claims	Public nuisance; Washington Consumer Protection Act
Consumer payout	None; no claim form or class
Albertsons’ position	Denies wrongdoing; considering an appeal
Official announcement	Washington Attorney General, November 5, 2026

What Is the Washington State Albertsons Pharmacy Lawsuit About?

Washington argued that pharmacies are a checkpoint in the controlled-substance supply chain. Doctors write prescriptions and distributors supply drugs, but pharmacies must identify warning signs, investigate them and keep records before dispensing. The state alleged that Albertsons and Safeway fell short between 2006 and 2022 by:

• Dispensing opioids despite unresolved warning signs.
• Failing to investigate suspicious prescribing patterns.
• Operating pharmacies without adequate staffing.
• Failing to maintain effective systems for identifying suspicious distribution orders.
• Accepting cash and discount-card payments for controlled substances despite known risks.
• Failing to monitor opioid inventory and report theft.
• Continuing to fill prescriptions from high-volume prescribers after concerns were raised.

The evidence also included corporate policies that allegedly put volume ahead of safety and discouraged pharmacists from flagging problem prescribers. In one example cited by the state, a pharmacy filled more than 5,000 opioid pills for a single customer over several visits in a short period.

Which Albertsons, Safeway and Haggen Pharmacies Were Involved?

Albertsons acquired Safeway in 2015. When the complaint was filed, the court’s findings identified about 44 Albertsons, 170 Safeway and 13 Haggen pharmacies in Washington. The judgment is against Albertsons Companies, Inc. and Safeway, Inc., which the judge refers to together as Albertsons. Safeway operations are central to the case.

How Did the Washington Albertsons Opioid Lawsuit Begin?

Attorney General Bob Ferguson filed the complaint on December 21, 2022. It named Albertsons, Safeway, The Kroger Company, Fred Meyer, Quality Food Centers, Rite Aid Corporation, Rite Aid Headquarters Corporation, Thrifty Payless, Inc. and Bartell Drugs Company. The state pursued public nuisance and Consumer Protection Act claims.

Why Was Albertsons the Only Defendant at Trial?

The Attorney General said the other companies either settled early or declared bankruptcy. Albertsons remained the only defendant in the part of the case that went to trial. On April 14, 2026, Albertsons announced a $774 million national opioid settlement framework with state, local and tribal governments, with no admission of liability. Washington did not join it and continued its own case.

What Was the Earlier Safeway DEA Enforcement Action?

The November 2026 opinion discusses earlier federal enforcement. When Albertsons acquired Safeway in 2015, Safeway was subject to a Drug Enforcement Administration (DEA) action involving failures to report the diversion of more than 104,000 opioid pills. In 2017, Safeway entered an administrative agreement with the DEA and agreed to a $3 million civil penalty. Its North Bend, Washington, pharmacy also faced a six-month suspension of its authority to dispense controlled substances, with four months imposed starting September 18, 2017 and two held in abeyance.

That was a separate federal resolution and is not part of the $900 million judgment. The court considered it when examining the company’s later controlled-substance policies.

What Did the Judge Find About 6.28 Million Opioid Prescriptions?

The court examined dispensing records for 2006 through 2022:

Finding	Number
Opioid prescriptions dispensed	10,615,250
Prescriptions with at least one red flag	6,541,993 (about 61.63%)
Red-flagged prescriptions with no documented resolution	6,280,313

The judge treated each of the 6,280,313 undocumented prescriptions as a separate Consumer Protection Act violation for penalty purposes, and found that about 96% of red-flagged prescriptions lacked documentation of how the warning sign was resolved. A red flag is a prompt to investigate. It does not prove that a patient obtained a drug illegally or that a prescription was inappropriate.

Which Red Flags Did the Court Consider?

The court considered 14 categories of diversion indicators, including:

• Long-distance travel to the pharmacy or the prescriber.
• Multiple opioid prescribers or multiple pharmacies.
• High-risk combinations of opioids, benzodiazepines and muscle relaxants.
• Early refills.
• High dosages.
• Cash payments.

A person can have a legitimate reason for any of these. The legal duty is to look at the circumstances and document the decision.

Why Did Documentation Matter?

Without records showing what was identified, what was investigated and why the prescription was filled, the company could not show the required due diligence occurred.

How Many Opioid Pills Did Albertsons Dispense in Washington?

Between 2006 and 2022, Albertsons pharmacies dispensed about 640,682,383 opioid pills in Washington, including 283,410,896 hydrocodone and 252,877,921 oxycodone pills. When operating as its own distributor, the company also sent more than 30.2 million opioid pills to its own Washington pharmacies. Many opioid prescriptions are medically legitimate. The question was whether the company’s systems caught and investigated those with warning signs.

What Did the Court Find About High-Risk Prescribers?

Reuters reported that Judge Helson identified more than 5.5 million opioid pills dispensed on prescriptions from five prescribers whose licenses were later suspended. The judge found Albertsons sometimes kept filling prescriptions from questionable high-volume prescribers after concerns were raised, including by pharmacists.

What Did the Court Find About Discount Cards and Cash Payments?

Discount cards, such as GoodRx, and cash let patients pay outside insurance, which can avoid insurer limits on opioid quantity or duration. According to the opinion, an internal review over six months showed Albertsons dispensed more than 625,000 controlled-substance prescriptions paid with discount cards and more than 75,000 paid in cash, with a combined value above $21.1 million. The judge found other pharmacy chains had stopped accepting discount cards for opioids years earlier while Albertsons continued. She did not find that every patient using a discount card or cash acted improperly. The finding was that the company did not use these signs in an effective prescription-review system.

How Many Opioid Pills Were Stolen From Albertsons and Safeway Pharmacies?

The court found Safeway and Albertsons reported theft or loss of at least 115,000 opioid pills from Washington stores between 2010 and 2024, including more than 70,000 over about two years at a North Bend pharmacy, about 12,000 at Leavenworth and about 19,000 at Olympia. Evidence also showed company policy directed employees to report some losses internally rather than directly to the DEA. The judge concluded the inventory controls were inadequate and contributed to preventable diversion.

Why Did Pharmacy Understaffing Matter in the Albertsons Opioid Case?

The state argued Albertsons ran understaffed pharmacies where pharmacists lacked time for meaningful reviews. The court heard testimony and saw internal messages describing exhaustion and heavy workload, and evidence of difficulty taking scheduled breaks. It also discussed a September 2022 Washington Department of Health deficiency at a Kirkland store, where the department said insufficient staffing could lead to substandard care and patient harm. The judge concluded the staffing problems were systemic and undermined pharmacists’ ability to perform controlled-substance due diligence. A company cannot rely on pharmacists to investigate suspicious prescriptions without giving them staffing, training, technology and time.

What Happened at the 2026 Albertsons Opioid Trial?

The bench trial ran from July 13 to September 14, 2026, about nine weeks, before Judge Helson with no jury. Forty-five witnesses testified and more than 600 exhibits were admitted. Sixteen Albertsons employees gave deposition testimony and one testified live. Albertsons also presented experts and current pharmacy leadership.

What Did Albertsons Argue?

Albertsons said it dispensed legally prescribed medications written by licensed physicians, and that pharmacists need not question a doctor’s judgment without a compelling reason to suspect a prescription was illegitimate. It also pointed to other causes of the crisis, such as manufacturer marketing, prescriber practices and policy decisions. The judge rejected the company’s central legal defenses and held that filling a prescription written by a licensed doctor does not eliminate a pharmacy’s corresponding responsibility.

What Did the Court Decide Before Trial?

On June 1, 2026, Judge Helson denied Albertsons’ motions for summary judgment on the Consumer Protection Act and public nuisance claims. She also granted Washington’s motion for partial summary judgment on Albertsons’ duties under federal and Washington law, which set the legal framework for the trial.

What Did the November 5, 2026 Judgment Order Albertsons to Pay?

Component	Amount
Opioid-crisis abatement	$800 million
Civil penalties (while abatement stands)	$100 million
Total while the abatement award stands	$900 million
Attorney fees and litigation costs	Additional; not yet quantified

The $800 Million Abatement Award

Washington had asked for $2.2 billion. The judge set $800 million, to fund treatment, harm reduction, primary prevention, and coordination and monitoring. Washington must create a court-supervised trust to hold the money and submit governing documents for approval, and the court keeps jurisdiction over the trust. The ruling says Albertsons will not control how the state designs or runs the abatement plan simply because it funds it. The money will not be available immediately while any appeal proceeds.

The $100 Million in Civil Penalties

The court’s underlying calculation was higher:

Violation category	Penalty
11,953 distribution violations	$23,906,000
6,280,313 dispensing violations	$314,015,650
Total calculated Consumer Protection Act penalties	$337,921,650

The figures work out to $2,000 for each distribution violation and $50 for each dispensing violation. The judge reduced the penalty to $100 million while the $800 million abatement order stands.

Could the penalty rise? Yes. If the abatement award is reduced or eliminated, including on appeal, the civil penalty increases to $337,921,650. The $100 million figure is therefore not an unconditional ceiling.

Attorney Fees and Costs

The court held that Washington is the prevailing party and entitled to reasonable fees and costs. The state must file its petition within 21 days of the findings and conclusions. The amount is undetermined.

What Does the Permanent Injunction Require From Albertsons and Safeway?

The court’s permanent injunction requires Albertsons to:

1. Resolve and document red flags before dispensing. A covered prescription with a warning sign cannot be filled until a pharmacist resolves it and documents the basis.
2. Build warning-sign alerts into pharmacy software for controlled-substance prescriptions.
3. Check the Washington Prescription Monitoring Program record before dispensing a controlled-substance prescription.
4. Staff pharmacies adequately so the reviews can be done and documented.
5. Run a compliance program that monitors dispensing at every Washington pharmacy.
6. Audit dispensing regularly, report findings to the compliance department and correct violations.
7. Monitor suspicious distribution orders. If it distributes controlled substances to its Washington pharmacies, Albertsons must identify orders of unusual size, frequency or pattern, investigate before shipping, and report suspicious orders to the DEA.
8. Certify compliance annually. For five years, a responsible officer must certify compliance under oath to the Attorney General and produce dispensing-review and audit records on request.

The court retains jurisdiction to enforce the injunction. The ruling does not order any pharmacy to close.

What Laws Did the Court Apply in the Washington v. Albertsons Opioid Case?

Federal Controlled Substances Act, 21 U.S.C. § 801 et seq.

The Controlled Substances Act regulates the manufacture, distribution and dispensing of controlled substances. Registrants must keep systems that prevent diversion. Related provisions include 21 U.S.C. § 829 (prescription requirements), § 841 (unlawful distribution) and § 842 (civil penalties for registrant violations).

21 CFR § 1306.04(a): Corresponding Responsibility

A controlled-substance prescription must be issued for a legitimate medical purpose by a practitioner acting in the usual course of practice. The regulation places a corresponding responsibility on the pharmacist who fills it. A pharmacist cannot assume every signed prescription is legitimate, and the court relied on this principle in rejecting Albertsons’ argument that pharmacists should generally defer to prescribers. The Supreme Court addressed the mental-state requirement in criminal prosecutions under § 841 in Ruan v. United States, 597 U.S. 450 (2022). This case is a civil enforcement action.

21 CFR § 1301.74: Suspicious Orders

Distributors must design and operate a system to identify suspicious orders (unusual size, pattern or frequency) and report them to the DEA. The court found Albertsons failed to maintain an effective system or report the orders at issue.

21 CFR §§ 1301.71 and 1301.76: Security and Theft Reporting

Registrants must maintain effective controls against theft and diversion. Under § 1301.76(b), a theft or significant loss must be reported to the DEA in writing within one business day of discovery, followed by a completed DEA Form 106 within 45 days. The court relied on these provisions in evaluating the missing and stolen pills.

Washington Uniform Controlled Substances Act, RCW Chapter 69.50

RCW 69.50.308(h) requires prescriptions to be issued in good faith for a legitimate medical purpose. The judge held Albertsons could not use a general duty to fill lawful prescriptions to excuse ignoring warning signs.

Washington Pharmacy and Monitoring Laws, RCW 18.64 and RCW 70.225

RCW chapter 18.64 is Washington’s pharmacy practice law, and RCW chapter 70.225 governs the state Prescription Monitoring Program that the injunction requires pharmacists to review.

WAC 246-945-410: Pharmacy Staffing and Facility Standards

Pharmacies must be staffed sufficiently to allow appropriate supervision and safe operation. The court found Albertsons’ staffing violated this requirement and undermined prescription reviews.

Washington Consumer Protection Act, RCW 19.86

RCW 19.86.020 prohibits unfair or deceptive acts or practices in trade or commerce. The state generally must show an unfair or deceptive act or practice, in trade or commerce, that affects the public interest. Under RCW 19.86.080, the Attorney General can seek injunctions and other relief, including costs and reasonable attorney fees. RCW 19.86.140 authorizes civil penalties per violation, up to $7,500 for violations of RCW 19.86.020 under the current statute. The court also considered the earlier $2,000 maximum for certain violations before the July 25, 2021 amendment, which matches the $2,000 per distribution violation in its calculation. In State v. Ralph Williams’ North West Chrysler Plymouth, Inc., 87 Wn.2d 298 (1976), the Washington Supreme Court addressed factors for setting Consumer Protection Act penalties.

Washington Public Nuisance Law, RCW Chapter 7.48

RCW 7.48.120 defines nuisance, and RCW 7.48.130 defines public nuisance as an act or omission that unlawfully affects the property, health or safety of a considerable number of people. The judge found Albertsons’ conduct substantially contributed to the opioid oversupply and resulting public-health crisis. She did not find Albertsons the only cause. The ruling acknowledged that manufacturers, prescribers, other distributors and policy choices also contributed. Abatement remedies follow under chapter 7.48.

Appeal Procedure: Washington Rules of Appellate Procedure

A notice of appeal is generally due within 30 days of entry of the decision (RAP 5.2). Staying enforcement of a money judgment during an appeal generally requires a supersedeas bond or other security under RAP 8.1. The conditional increase in the civil penalty is designed to apply if the abatement award is cut on appeal.

Official legal sources:

• 21 CFR § 1306.04
• 21 CFR § 1301.74
• 21 CFR § 1301.76
• RCW 69.50, Uniform Controlled Substances Act
• RCW 19.86, Consumer Protection Act
• RCW 7.48.120
• WAC 246-945-410

What Did Albertsons Say After the $900 Million Ruling?

Albertsons expressed disappointment and said it was considering an appeal. Its position throughout has been that its pharmacists served patients responsibly and that it met its legal obligations. It has not admitted liability.

How Does the $900 Million Judgment Relate to Albertsons’ $774 Million National Opioid Settlement?

Issue	National settlement framework	Washington judgment
Date	April 14, 2026	November 5, 2026
Amount	$774 million	$900 million
Type	Negotiated framework	Court ruling after trial
Parties	Participating state, local and tribal governments	State of Washington and Albertsons
Liability	No admission, per Albertsons	Court found legal violations
Washington’s role	Did not join; continued its own case	Prevailed at trial

They are separate developments, and the amounts should not be assumed to add up to a single payment to Washington. Neither creates a consumer compensation program. Washington has recovered nearly $2.2 billion in total from opioid litigation against manufacturers, distributors and pharmacies, according to reporting. Funds go to prevention, treatment and recovery programs at the state and local level.

For other pharmacy opioid litigation, see Walgreens Whistleblower T.J. Novak’s $25.875 Million Award and Bid for More Settlement Money Goes To State Courts. For the wider national history, see Oxycodone Lawsuit, $7.4 Billion Settlement Approved—Purdue Pharma Who Make OxyContin & Sacklers Ordered to Pay After Supreme Court Rejection.

Is the Washington State Albertsons Pharmacy Lawsuit a Class Action?

No. It is an enforcement case brought by the State of Washington through its Attorney General, not by customers or families seeking personal compensation. There is no class, claims administrator or individual payout schedule.

Can Albertsons and Safeway Pharmacy Customers Receive Money From the Judgment?

No. The $800 million goes into a court-supervised trust for treatment, prevention and harm reduction. The $100 million civil penalty is payable to the state. The judge declined a separate restitution award. So:

• There is no claim form or filing deadline.
• Filling an opioid prescription at an Albertsons or Safeway pharmacy does not qualify anyone for payment.
• The judgment creates no wrongful-death or personal-injury claim process. Individual legal claims, where available, depend on separate facts and deadlines.

Is This the Same as the Washington Albertsons BOGO Lawsuit?

No. On April 27, 2026, Attorney General Nick Brown filed a separate consumer protection lawsuit alleging deceptive buy-one-get-one-free promotions at Albertsons, Safeway and Haggen stores, involving more than 3.1 million transactions.

Opioid lawsuit	BOGO lawsuit
Filed December 21, 2022	Filed April 27, 2026
Prescription opioid dispensing and distribution	Grocery promotional pricing
Public nuisance and controlled-substance laws	Consumer protection and deceptive pricing
$900 million trial ruling, November 5, 2026	Separate pricing litigation

For the other case, see Washington State vs. Albertsons Companies BOGO Pricing Lawsuit, Full Case Breakdown.

What Happens Next in the Washington Albertsons Opioid Case?

1. Appeal. Albertsons says it is considering one. It could challenge the findings, legal conclusions or remedies.
2. The abatement trust. Washington must create it and obtain court approval of its governing documents.
3. Fees and costs. The state’s petition is due within 21 days of the findings, and the amount is undetermined.
4. Injunction compliance. The court retains jurisdiction, and the company must certify compliance annually for five years.
5. Changes on appeal. A reduction in the abatement award would trigger the $337,921,650 alternative penalty.

As of November 6, 2026, no completed appeal or appellate decision had been verified.

Washington State Albertsons Pharmacy Lawsuit: Frequently Asked Questions

How much did Washington win in the Albertsons pharmacy lawsuit?

A $900 million trial-court judgment on November 5, 2026: $800 million for abatement and $100 million in civil penalties while the abatement award stands, plus attorney fees and costs.

Why was Albertsons ordered to pay $900 million?

The judge found Albertsons and Safeway failed to maintain adequate systems to identify and investigate suspicious opioid prescriptions and distribution orders, and found problems with staffing, compliance, cash and discount-card payments and theft controls.

How many opioid prescriptions were involved?

6,541,993 prescriptions filled from 2006 to 2022 had at least one red flag, and 6,280,313 lacked documentation that the warning sign was resolved.

How many opioid pills did Albertsons dispense in Washington?

About 640.68 million between 2006 and 2022.

Did Albertsons admit wrongdoing?

No. It disputed the claims and said it is considering an appeal.

Can I file an Albertsons opioid settlement claim?

No. The judgment created no individual claim program.

Will Safeway pharmacies have to change how they operate?

Yes. The injunction requires red-flag investigations, adequate staffing, Prescription Monitoring Program checks, compliance monitoring and annual certification.

Does the ruling mean every opioid prescription filled at Safeway was illegal?

No. The findings concern the company’s compliance systems and prescriptions with warning signs that were not resolved and documented.

Was this a lawsuit against individual pharmacists?

No. The State sued the corporate defendants, and the ruling examined companywide practices. It created no criminal convictions against individual pharmacists.

Is the $900 million part of the $774 million national settlement?

No. Washington did not join the national framework and won this judgment through its own litigation.

Can Albertsons appeal?

Yes, under Washington appellate procedure. It has said it is considering its options.

When will Washington receive the money?

Albertsons must fund the court-supervised $800 million trust. The payment and implementation schedule depends on later court orders and trust documents, and any appeal could affect it.

Will the ruling close Albertsons or Safeway pharmacies?

No. It imposes financial obligations and permanent compliance requirements, not closures.

The Bottom Line on Washington’s $900 Million Albertsons Opioid Judgment

After a nine-week trial, Judge Helson found that Albertsons and Safeway substantially contributed to Washington’s opioid crisis. The November 5, 2026 judgment orders $800 million for abatement, $100 million in civil penalties while the abatement stands, attorney fees and costs, and a permanent injunction. The findings include 6,280,313 prescriptions with unresolved and undocumented warning signs, about 640.68 million opioid pills dispensed, systemic staffing and compliance failures, and at least 115,000 opioid pills lost or stolen. Albertsons disputes the ruling and is considering an appeal. For Washington residents, the key point is that this is a government abatement judgment, not a consumer class action.

Sources and Court Records

Primary court records

1. King County Superior Court, State of Washington v. Rite Aid Corp. et al., No. 22-2-20910-1 SEA, Findings of Fact and Conclusions of Law, November 5, 2026 (Judge Janet M. Helson, 219 pages). Read the signed decision (PDF)
2. Washington Attorney General’s Office, original December 21, 2022 complaint (PDF)

Official announcements

3. Washington Attorney General, November 5, 2026: Washington Wins $900 Million Verdict Against Albertsons for Fueling Opioid Crisis
4. Washington Attorney General, July 10, 2026: Washington Attorney General’s Office Begins Trial Against Albertsons for Fueling Opioid Crisis
5. Washington Attorney General, December 21, 2022: AG Ferguson Files Lawsuits Against Three National Pharmacy Chains for Their Role in Fueling the Opioid Crisis
6. Albertsons Companies, April 14, 2026: Albertsons Announces National Opioid Settlement Framework (SEC filing)

News reporting

7. Reuters, November 5, 2026: Albertsons Must Pay $900 Million for Fueling Opioid Epidemic in Washington State, Judge Rules
8. Courthouse News Service, November 5, 2026: Judge Orders Albertsons to Pay Washington $900 Million Over Role in Opioid Crisis

Laws and regulations

9. 21 U.S.C. §§ 801 et seq., 829, 841, 842; 21 CFR §§ 1301.71, 1301.74, 1301.76, 1306.04
10. RCW chapters 7.48, 18.64, 19.86, 69.50 and 70.225; WAC 246-945-410; Washington Rules of Appellate Procedure 5.2 and 8.1
11. Ruan v. United States, 597 U.S. 450 (2022); State v. Ralph Williams’ North West Chrysler Plymouth, Inc., 87 Wn.2d 298 (1976)

Research note: The court’s findings and remedies rely on the signed November 5, 2026 decision as described in the sources above. The $800 million abatement and the conditional civil-penalty calculation are alternatives and are not presented as cumulative payments. No consumer claim eligibility or payout is implied.

Disclaimer: This article is legal information, not legal advice, and AllAboutLawyer.com is not a law firm. Outcomes may change as further court orders or appeals are entered.

Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. All facts verified against the signed findings and conclusions in No. 22-2-20910-1 SEA, Washington Attorney General releases, Albertsons’ SEC filing, Reuters and Courthouse News reporting, and the cited federal and Washington laws, as of November 6, 2026. Last Updated: November 6, 2026.